UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C. 20549

                             FORM 8-K

                          CURRENT REPORT
   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report(Date of earliest event reported):  March 24, 2011

                     OPT-SCIENCES CORPORATION
       (Exact name of registrant as specified in its charter)

             New Jersey                 0-1455                21-0681502
    (State or other jurisdiction  (Commission File Number)  (IRS Employer
   of incorporation or organization)                      Identification No.)

        1912 Bannard Street, Cinnaminson, New Jersey     08077
         (Address of principal executive offices)      (zip code)

Registrant's telephone number, including area code: (856) 829-2800

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the
    Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the
    Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
    under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
    under the Exchange Act (17 CFR 240.13e-4(c))

                      INFORMATION TO BE INCLUDED IN THE REPORT

ITEM 5.07	ELECTION OF DIRECTORS

At the Annual Meeting of Shareholders held on March 24, 2011, a total of
535,640 shares (or approximately 69% of all outstanding shares) owned by the
Arthur J. Kania Trust, Arthur J. Kania and Anderson L. McCabe was voted in
favor of the reelection of each of the management slate of directors, namely
Anderson L. McCabe, Arthur J. Kania and Arthur J. Kania, Jr. The Company
did not solicit proxies from other shareholders and no such other shareholders
voted their shares at the meeting, either in person or by proxy.

SIGNATURES

Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

OPT-SCIENCES CORPORATION

By: /s/Anderson L. McCabe
    ----------------------------------
    President, Chief Executive Officer
    and Chief Financial Officer

Date: March 25, 2011